BKM1644 effectively inhibits the proliferation of metastatic, castration-resistant PCa (mCRPC) cells. References: Zhang S, Gera L, Mamouni K, Li X, Chen Z, Kucuk O, Wu D. Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative. Oncotarget. 2016 May 10;7(19):27489-98. doi: 10.18632/oncotarget.8481. PubMed PMID: 27050371; PubMed Central PMCID: PMC5053666.

纯度：≥98%

CAS：1070966-96-9